Relationship between plasma desipramine levels, CYP2D6 phenotype and clinical response to desipramine: a prospective study (Q73108461)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9049581%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Relationship between plasma desipramine levels, CYP2D6 phenotype and clinical response to desipramine: a prospective study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9049581%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9049581%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Giuseppe M. Campo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9049581%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

C Gitto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9049581%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A Avenoso

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9049581%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A P Caputi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9049581%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

E Perucca

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9049581%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9049581%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9049581%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9049581%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9049581%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

395-398

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9049581%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s002280050220

1 November 2019

exact match

0 references

cites work

Pharmacogenetic aspects in the metabolism of psychotropic drugs: pharmacokinetic and clinical implications.

1 reference

https://api.crossref.org/works/10.1007%2FS002280050220

The debrisoquine hydroxylation test predicts steady-state plasma levels of desipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002280050220

Plasma concentrations of nortriptyline and its 10-hydroxy metabolite in depressed patients--relationship to the debrisoquine hydroxylation metabolic ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002280050220

Steady-state concentrations of imipramine and its metabolites in relation to the sparteine/debrisoquine polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002280050220

Urinary desipramine hydroxylation index and steady-state plasma concentrations of imipramine and desipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002280050220

Slow hydroxylation of nortriptyline and concomitant poor debrisoquine hydroxylation: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002280050220

Genetically determined drug-metabolizing activity and desipramine-associated cardiotoxicity: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002280050220

Importance of oxidative polymorphism on clinical efficacy and side-effects of imipramine--a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002280050220

Hydroxylation of desmethylimipramine: dependence on the debrisoquin hydroxylation phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002280050220

Development of a Rating Scale for Primary Depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002280050220

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002280050220

Benzodiazepines and tricyclic antidepressant plasma levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002280050220

High‐Performance Liquid Chromatographic Assay for Imipramine, Desipramine, and Their 2‐Hydroxylated Metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002280050220

Imipramine: Clinical effects and pharmacokinetic variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002280050220

Clinical implications of imipramine plasma levels for depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002280050220

Relationship between plasma level and therapeutic effect of nortriptyline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002280050220

Desipramine plasma concentration and antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002280050220

Desipramine and 2-hydroxydesipramine plasma levels in endogenous depressed patients. Lack of correlation with therapeutic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002280050220

Active metabolites of imipramine and desipramine in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002280050220

Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002280050220

Extremely rapid hydroxylation of debrisoquine: a case report with implication for treatment with nortriptyline and other tricyclic antidepressants.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9049581

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Genetically variable metabolism of antidepressants and neuroleptic drugs in man.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9049581

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S002280050220

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9049581%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference